Pico-Salax (ingredients: sodium picosulfate, magnesium oxide, citric acid) is the only dual-action purgative approved by the FDA when the cleansing of the bowel is required in preparation for a colonoscopy. It can be used for colonoscopies on children over the age of one. Off-label uses for Pico-Salax include preparation for other investigative procedures such as CT colonography, flexible sigmoidoscopy and barium enema x-rays, or surgical procedures, that require a clean colon. Chronic constipation can also be treated with appropriate dosing. Dosage The dosing for each use will be stipulated by the prescribing physician. Read the instructions in the box carefully. Pico-Salax comes in two packets per box, as a powder for reconstitution. Each of the two packets contains 10 mg of sodium picosulfate, 3.5 grams of magnesium oxide, 12 grams of anhydrous citric acid and a marked measuring cup. The contents of both packets constitute a complete bowel cleansing regimen. The powder must be reconstituted with cold water immediately before use and should not be prepared in advance. The usual treatment for chronic constipation is one-half of a sachet of Pico-Salax given every alternate day, three times a week.
Brand Manufacturer: Ferring
Side Effects: Please read the manufacturer’s Product Insert leaflet that comes with the medication before using it. Not all possible side effects can be listed. If you experience any of these or any other unexpected side effects, seek medical attention from your prescribing physician. By its nature, Pico-Salax dosing can induce several effects that may be termed adverse. Gastrointestinal adverse reactions are expected, including abdominal bloating, distension, abdominal pain or cramping, fecal urgency, and watery diarrhea. Nausea, headaches and vomiting have also been reported in a small number of cases.
Indication: Colorectal cancer is ranked third in terms of the number of new cases of cancer and has been the third leading cause of cancer deaths among adult men and women despite having a high survival rate with early detection. Screening with colonoscopy is recommended in the general population every ten years beginning at age 50 or earlier in the case of African American adults. More frequent screening may be required when polyps or other abnormalities have previously been found. The investigative procedure of a colonoscopy requires a full purge of the colon. Pico-Salax is a preferred agent acting as an easy-to-administer purgative with dual-action osmotic and stimulant laxative properties. Pico-Salax is also being prescribed off-label for similar investigative procedures and for bowel surgery. Patients with chronic constipation can be prescribed lower doses of Pico-Salax to induce loose stools and complete spontaneous bowel movements.